Skip to main content

Table 2 Median difference between arterial (A) and jugular (J) venous cytokine concentrations

From: Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury

Cytokine

Abbreviation

A–J [pg/mL]

Epidermal growth factor

EGF

1.19

Eotaxin

Eotaxin

− 0.207

Basic fibroblast growth factor

FGF.2

0.641

Fms-related tyrosine kinase 3 ligand

FLT.3.ligand

− 2.053

Fractalkine/CX3CL

Fractalkine

− 0.662

Granulocyte colony-stimulating factor

G.CSF

− 3.413

Granulocyte-monocyte colony stimulating factor

GM.CSF

− 0.388

GRO/CXCL3

GRO

20.593

Interferon alpha-2

IFNa2

0.476

Interferon gamma

IFNg

− 0.172

Interleukin-1 alpha

IL.1a

1.654

Interleukin-1 beta

IL.1b

− 0.055

Interleukin-1 receptor antagonist

IL.1ra

2.157

Interleukin-2

IL.2

0.313

Interleukin-3

IL.3

− 0.004

Interleukin-4

IL.4

0

Interleukin-5

IL.5

0.084

Interleukin-6

IL.6

3.942

Interleukin-7

IL.7

0.139

Interleukin-8

IL.8

1.87

Interleukin-9

IL.9

− 1.634

Interleukin-10

IL.10

0.894

Interleukin-12 subunit beta

IL.12.p40

0

Interleukin-12

IL.12.p70

0.004

Interleukin-13

IL.13

0.232

Interleukin-15

IL.15

0.334

Interleukin-17

IL.17

0.061

Chemokine (C-X-C motif) ligand 10

IP.10

− 1.628

Monocyte chemotactic protein 1

MCP.1

− 0.658

Monocyte chemotactic protein 3

MCP.3

0

Macrophage-derived chemoattractant

MDC

19.1

Macrophage inflammatory protein-1 alpha

MIP.1a

1.333

Macrophage inflammatory protein-1 beta

MIP.1b

2.014

Platelet-derived growth factor AA

PDGF.AA

19.988

Platelet-derived growth factor AB/BB

PDGF.ABBB

201.807

RANTES

RANTES

88.263

Soluble CD40 Ligand

sCD40L

16.129

Soluble interleuking-2 receptor

sIL.2Ra

7.785

Transforming growth factor alpha

TGFa

0.47

Tumour necrosis factor alpha

TNFa

0.7

Tumour necrosis factor beta

TNFb

0.741

Vascular endothelial growth factor

VEGF

2.574